Do you have lupus? We want to learn if Mycophenolate Mofetil (MMF) and voclospoporin medications used in this study are the same or better at treating lupus outside the kidney (SLE)

Are you a patient with locally advanced or metastatic squamous cell carcinoma? If so, you may be eligible to participate in a clinical research study involving an investigational drug, NBTXR3.

Do you have newly-diagnosed multiple myeloma? If so, you may be able to participate in a research study looking at the safety, efficacy, and tolerability of giving isatuximab in combination with lenalidomide and dexamethasone at lower doses.

Can we increase the clinical complete response rate (tumor disappears by exam, endoscopy, and imaging) by adding a 3rd drug (irinotecan) to the standard regimen of FOLFOX or CAPOX given following long-course chemoradiation for patients with locally advanced rectal cancer? We are doing this study because we want to find out if this approach is better or worse than the usual approach for your rectal cancer. The usual approach is defined as care most people get for locally advanced rectal cancer.

Have you been diagnosed with multiple myeloma that has not responded to treatment or has come back after treatment? If so, you may be able to take part in a research study looking at the safety and efficacy of giving a new drug called ABBV-383 to patients with relapsed/refractory multiple myeloma.

Do you have a history of ACL reconstruction? You may be eligible to participate in a study using virtual reality and mindfulness meditation! We aim to explore psychological factors that may impact return to play outcomes after ACL reconstruction.

Do you have endometrial cancer? if so, you may be able to participate in an observational study that follows patients from diagnosis of endometrial cancer through one year post-treatment to learn more about how cancer treatment affects individual patients.

Do you have ovarian or peritoneal cancer? if so, you may be able to participate in a research study comparing the treatment of carboplatin/paclitaxel and letrozole hormonal therapy to letrozole alone to see if the treatment can shrink or stabilize your cancer.

We're all different. But when we visit the doctor, our treatments are often the same. We think one day health care should be tailored for you. This is called precision medicine. And research can help us get there. Taking part in the All of Us Research Program involves sharing information about your health, habits, and what it's like where you live. If you are 18 or older and live in the United States, you may be able to take part!

Have you been diagnosed with Metastatic Castration-Resistant Prostate Cancer. If so, you may be able to take part in a research study looking at the safety of giving Docetaxel vs Docetaxel and Radium-223 to patients.